Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19596163 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease
Condition: Proteinuric Renal Disease
Intervention: Drug: paricalcitol (initial dose 1 mcg orally per day)

Indicates status has not been verified in more than two years